A Case of Thrombocytosis Associated with Enoxaparin Therapy in an Adolescent
Robert Murray,1 Joseph T Tobias1– 3 1Department of Pediatrics, Division of Pediatric Critical Care Medicine, Nationwide Children’s Hospital, Columbus, OH, USA; 2Department of Anesthesiology & Pain Medicine, Nationwide Children’s Hospital, Columbus, OH, USA; 3Department of Anesthesiology & Pa...
Guardado en:
Autores principales: | Murray R, Tobias JT |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/86d8dc236440452a8d2c395a8746fd30 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications
por: Tahaineh L, et al.
Publicado: (2018) -
Enoxaparin‐induced bullous hemorrhagic dermatosis at a distant location from the injection site
por: Abdulrahman F. Al‐Mashdali, et al.
Publicado: (2021) -
Beneficial Effects of Anticoagulants on the Clinical Outcomes of COVID-19 Patients
por: Zubia Jamil, et al.
Publicado: (2021) -
Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting
por: Harry Menon, et al.
Publicado: (2018) -
The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false‐positive results?
por: Pieter M.M. De Kesel, et al.
Publicado: (2020)